Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Accr4g02609 ATGAACATGACAATCGCACCATGGAAGTATCATGTTTTCTTGAGCTTCAGAGGAGAAGACACCCGAAAAGGCTTCACAGACCACTTAAACGCTACTCTAAAACAAAGAGGTATCATAACTTTCTTAGATGATAAGCTCAATAAAGGAGAGGTTATTTCTGATCAACTCCTCTTAGCAATTGATGAATCTCTCATCTCTCTTGTTATTCTCTCTGAAAGTTATGCCTCTTCTAGATGGTGTTTGGATGAACTTCAAAGGATTCTTGAATCTAAAAAATCTTTGGGTAGAGAAGTTATCCCAATCTTCTATAAGGTTGATCCGTCTGATGTGCGTTATCAAAGAGGTACCTTTGGTTGCGCCCTTCAAAAACATGGTGACAGATTTGCTGAAAACAAAGACAAGGTGCAAAGATGGAAAGATGCCTTAAAAGAAGTTGCAAATATATCAGGCTATGACTCTAGGGACCGGAATGAAGGGAAACTCATTGAAGAAATTGTTGCAGACGTATGGTCAAAGCTACAACCTAAATTATCATATTGTTTCAGTAACGAGCTTGTTGGCATTGAATCAAAGATAGAGCAAGTGAATTCACTTTTAAAGATTGGATTGGATGATGGTCGTCGTCGCTTCCTAGGAATTTGGGGCATGGGTGGTATAGGTAAAACAACTCTTGCAAGAGAGATCTTTGAGAGAATATGTGGCGACTTTGACATGAGTTGTTTTCTCGCTAATGTTAAAGAAAAATCTGAAACCAAGCAGGGTTTGGTTTACTTGCAAAGAAGACTTCTTTCCAAACTCAAGATAAGAGACTTAGAAGTTGATGATACATATGAGGGAAGGAATCTAATAAGAAACTTGCTGTGCAACAAAAAACTTCTACTTGTGTTGGATAATGTAAGTGAAATAAGCCAACTAGAAAACCTTTCAATAAAACAAGCCTGGTTGGGTTGTGGCAGTCGAGTAATAGTGACAACTAGGAATCTCCAAGTATTGATAGCACATGGAGAATTTGAAATATATGAGGCTGAATTATTAAATGATAATGAGTCTCTTCAACTTCTCTGCAAGAGGGCTTTTAAAAGGAATAAACCTAAAGAAGATTATGTGAAGTTGTGTAAAAGTTTCATACACTATGCTGCAGGCCTTCCTTTGACTCTTAAAGTGTTGGGTTCTTATCTTTGTGGGAAAAATGAACTTGAATGGAAAGTAGCTTTGGAGAAAATTAAAAAGTTCCCACCAGCGGATGTTCTGAAGAGACTTAGAGTAAGCTATGATGCATTAGGTGAAGTGGAAAAGAAAATTTTTTTGGATATTGCATGTTTTTTTAAAGGAATGGTCAAAGATCAAGTGACACAAATATTTGAAATAAGTGAACTTTATCCACAACTTGCAATAAGAGAACTTGTGGAGAAATGCTTGATAATTGAATACTATTCTGATCATGGGACTTGGTGTTTGGGTATGCATGATATCCTTCAAGAAATGGGTACAACTATTGTTTTGGAGGAATCACCTCATGATCCTAGCAGAAGAAGTAGATTATGGTCACTAAAAGATATTGATCGTGTGATGACAAAGAACAAAGGCTCAGACGTGCTGGAAGTGATACATCTTCAATCATCTACGCCATATGATTCAAATTGGGATCCTGAAGTATTCACTATGATATGCAATCTCAGAATACTTATCATAGCATGTGATTTACACCTTCCTCATGGCCTCAAATGTCTTCCTAGTTCACTAAAAATTCTTGAATGGAAATCATATCCTTTGAATTACCTTCCATCTGGTGGAAATCTAGATCAACTTGGTGTCCTTAAAATGCATCATAGCAAGATTGAACAACTTTGGAAGAGAACACATATTTTAGAAAAGTTGAAGCTCATTGATCTTAGTTATTCTGAAGAGTTTAGGACAACTCCTGATTTTTCGATGCTACCCAACCTGGAGCAACTGGTTCTTGAAGGTTGCATAAAACTTGTTGAGGTTCACCCATCACTTGCACAACATAAGAAACTACTTGTGCTGGACTTCAAAGATTGCAAGAATCTTAAAGCTCTTCCCACTAGAATGGAAATGGATTCATTGAATAAGTTGATCCTTTCAGGATGCTTGAAAATTAAGAAACTTCCAGAGTTTGGAAAAAATATGAGCAACCTATTGGTTCTTGATATGAAAAATTGCAAAAAGCTTGTTTGCCTTCCAAGTTCAATTTGTAACTTGAAATCTCTGAAAATTCTGAATATTTTAGGTTGCTCGAAATTTTCTTCATTGCCAGAAAACTTGAATGAAAATAACTGTCTAGAGGAGCTTGATTTGAGTGAAACTGCCATCAGAGAAATTCCTTCATCGACCATTGGCCTGCAAAATTTGAAGCTACTATATTTGAGAGGATGTAAAGGTTTGAGTTCAAGATCCAATTCATTAGTAAGGAGCTTGCTTTCCTCAGTTCAACAGGTATTTGGGCTTCATAATGAATCTCCCACAAGCTCCATGTATCTTTCTTTCATCTCAAGTATGGCATCGTTGAAGGAATTGAATTTAGAATACTGTAACCTGAAAGCTGGATCAATTCCAAATGAAATTCGTTGTTTAACAACATTGGAATATCTTAGTCTAGCTAGAAATGATTTTGGCAATGCATCCACAGGTAACTGGGCGCTTCCTCCTTCATTGAAGTGTTTAAAAATATCTAATTGTAATCTCAATGATGGTTCAATTCCTAATGACCTTAATAGCTTATCAGCATTGGAGACACTTAGTATAGGAGGAAACAATTTTACACATGTACCTGCTGGTTGTATCTCTAACCTCTTGCATCTTCGTAATCTTCATTTGAGTCACTGCCCATGGCTTAAGTTTCTGCCAGATCTCCCACCAAATTTACAACGTATTGATACCGTTGCTTGCCATTCATTGCAAACTTTGTCGTATCCAGAGTTGCTATTGAAGTGTATGGCTTTCTCAAATGTTTCCGTGGAATCTATTCCTCCTCATATGCACACAAATAACAACCGAGCTGGTATCTGGTGGACCCTAGGTGGTGAAATCCCATCATGGTTCCACAACCAAGATTTCAAAGTACTTGATAAAATTGAGAGTCGTGATGTTGTACAAGTTGATTCTGATTCCATTGTGTCAGTGGAAGTAGATGTCGCTGATTTTCGCGGTTCGAGTGGAAGTTGGGGAATTTCTCTTTGTGTTGTCGTACAAGATGTGAACCTTGATGATGATGTGTTCGATCTTTACCTTTGGATGACTCATAAAGCTTCAGAAGAAGAATTCGTTAAGAAAGACCTACGGTGGCGTGTTGTTTTTAGAGGGGATTCCCACCAAATCTTGACCATGTATTTGCCCTCCAGCAATTTTGCAGTTGATTGCATCAAGGTCGAATTCATATTTTATACAACAAAAACTATGTGTGGGGAAGCAGAATTGGATATGAAAGCCGACAGTGGAGATCATGGCAAGTTCATAATAAGCAAGTGTGGTTGGCGTGTGACACGCAAGGAAGATGTGGAAGAATGGCTCAGAACAATCCAAAAATGCAGCAGTACCAGTGACAACAATGAAATCCTTTCCGAAGAATCTGTGCACGGAAAGAGATACCGTGAAGGGGAAGAAGACCTGCAAGAAGAAGTCACTGTCAGTGAAACACATTCAGCTCGACAAAGTAAACTTAAAAGGTTTTCTTGA 3696 0.3774 MNMTIAPWKYHVFLSFRGEDTRKGFTDHLNATLKQRGIITFLDDKLNKGEVISDQLLLAIDESLISLVILSESYASSRWCLDELQRILESKKSLGREVIPIFYKVDPSDVRYQRGTFGCALQKHGDRFAENKDKVQRWKDALKEVANISGYDSRDRNEGKLIEEIVADVWSKLQPKLSYCFSNELVGIESKIEQVNSLLKIGLDDGRRRFLGIWGMGGIGKTTLAREIFERICGDFDMSCFLANVKEKSETKQGLVYLQRRLLSKLKIRDLEVDDTYEGRNLIRNLLCNKKLLLVLDNVSEISQLENLSIKQAWLGCGSRVIVTTRNLQVLIAHGEFEIYEAELLNDNESLQLLCKRAFKRNKPKEDYVKLCKSFIHYAAGLPLTLKVLGSYLCGKNELEWKVALEKIKKFPPADVLKRLRVSYDALGEVEKKIFLDIACFFKGMVKDQVTQIFEISELYPQLAIRELVEKCLIIEYYSDHGTWCLGMHDILQEMGTTIVLEESPHDPSRRSRLWSLKDIDRVMTKNKGSDVLEVIHLQSSTPYDSNWDPEVFTMICNLRILIIACDLHLPHGLKCLPSSLKILEWKSYPLNYLPSGGNLDQLGVLKMHHSKIEQLWKRTHILEKLKLIDLSYSEEFRTTPDFSMLPNLEQLVLEGCIKLVEVHPSLAQHKKLLVLDFKDCKNLKALPTRMEMDSLNKLILSGCLKIKKLPEFGKNMSNLLVLDMKNCKKLVCLPSSICNLKSLKILNILGCSKFSSLPENLNENNCLEELDLSETAIREIPSSTIGLQNLKLLYLRGCKGLSSRSNSLVRSLLSSVQQVFGLHNESPTSSMYLSFISSMASLKELNLEYCNLKAGSIPNEIRCLTTLEYLSLARNDFGNASTGNWALPPSLKCLKISNCNLNDGSIPNDLNSLSALETLSIGGNNFTHVPAGCISNLLHLRNLHLSHCPWLKFLPDLPPNLQRIDTVACHSLQTLSYPELLLKCMAFSNVSVESIPPHMHTNNNRAGIWWTLGGEIPSWFHNQDFKVLDKIESRDVVQVDSDSIVSVEVDVADFRGSSGSWGISLCVVVQDVNLDDDVFDLYLWMTHKASEEEFVKKDLRWRVVFRGDSHQILTMYLPSSNFAVDCIKVEFIFYTTKTMCGEAELDMKADSGDHGKFIISKCGWRVTRKEDVEEWLRTIQKCSSTSDNNEILSEESVHGKRYREGEEDLQEEVTVSETHSARQSKLKRFS 1231
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Accr4g02609 1231 Gene3D - 178 336 IPR027417 -
Accr4g02609 1231 Gene3D Ribonuclease Inhibitor 532 692 IPR032675 -
Accr4g02609 1231 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 176 438 IPR027417 -
Accr4g02609 1231 SMART till_3 9 148 IPR000157 GO:0007165
Accr4g02609 1231 MobiDBLite consensus disorder prediction 1194 1231 - -
Accr4g02609 1231 PRINTS Disease resistance protein signature 210 225 - -
Accr4g02609 1231 PRINTS Disease resistance protein signature 286 300 - -
Accr4g02609 1231 PRINTS Disease resistance protein signature 379 393 - -
Accr4g02609 1231 PRINTS Disease resistance protein signature 715 731 - -
Accr4g02609 1231 Pfam NB-ARC domain 191 418 IPR002182 GO:0043531
Accr4g02609 1231 SUPERFAMILY RNI-like 833 985 - -
Accr4g02609 1231 SUPERFAMILY Toll/Interleukin receptor TIR domain 6 151 IPR035897 -
Accr4g02609 1231 Gene3D Ribonuclease Inhibitor 693 822 IPR032675 -
Accr4g02609 1231 Gene3D - 344 428 IPR042197 -
Accr4g02609 1231 ProSiteProfiles TIR domain profile. 8 173 IPR000157 GO:0007165
Accr4g02609 1231 Gene3D Ribonuclease Inhibitor 823 1024 IPR032675 -
Accr4g02609 1231 Gene3D - 6 177 IPR035897 -
Accr4g02609 1231 Pfam TIR domain 9 187 IPR000157 GO:0007165
Accr4g02609 1231 MobiDBLite consensus disorder prediction 1194 1216 - -
Accr4g02609 1231 FunFam Disease resistance protein (TIR-NBS-LRR class) 6 175 - -
Accr4g02609 1231 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10 712 IPR044974 GO:0006952
Accr4g02609 1231 SUPERFAMILY L domain-like 488 878 - -
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Accr4g02609 Accr-Chr4 52700249 52708719 Dispersed/Transposed
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Accr4g02609 10 810 WRKY Transcription Factor Family AT4G12020 31.486 4.95e-96 337